Circadian Timing and Time Perception in Healthy Adults
ChronoTime
How Do Individual Differences in Circadian Rhythms Influence Time Perception?
2 other identifiers
interventional
128
1 country
1
Brief Summary
This study examines how a person's natural daily rhythm ("chronotype") affects the way time is experienced and judged. Healthy Danish-speaking adults (23-45 years) who are clearly morning-type or evening-type will complete two lab sessions in a crossover design: one at their preferred time of day (e.g., morning for morning-types) and one at the opposite time (misaligned). In each session, participants do brief computerized tasks that measure time estimation/production, vigilance (psychomotor vigilance task), decision-making, and responses to social information, plus simple color-vision tasks. Short questionnaires about sleepiness, mood, fatigue, and the subjective "passage of time" are collected before, during, and after testing. A subset will wear a wrist actigraphy device for one week beforehand to characterize sleep-wake patterns. Testing is conducted under standardized lab conditions with scheduled breaks. The main goal is to determine whether time judgments and vigilance are less accurate during the misaligned session and whether decision-making and social responses also vary with circadian timing. Risks are minimal and mainly relate to temporary tiredness when tested at a non-preferred time; participants may stop at any time. Participation is voluntary. Data are pseudonymized and handled under GDPR. Participants receive DKK 300 after completing both sessions (pro-rated if they withdraw early). Results will be published regardless of outcome, and de-identified data/code will be shared after publication.This study examines how a person's natural daily rhythm ("chronotype") affects the way time is experienced and judged. Healthy Danish-speaking adults (23-45 years) who are clearly morning-type or evening-type will complete two lab sessions in a crossover design: one at their preferred time of day (e.g., morning for morning-types) and one at the opposite time (misaligned). In each session, participants do brief computerized tasks that measure time estimation/production, vigilance (psychomotor vigilance task), decision-making, and responses to social information, plus simple color-vision tasks. Short questionnaires about sleepiness, mood, fatigue, and the subjective "passage of time" are collected before, during, and after testing. A subset will wear a wrist actigraphy device for one week beforehand to characterize sleep-wake patterns. Testing is conducted under standardized lab conditions with scheduled breaks. The main goal is to determine whether time judgments and vigilance are less accurate during the misaligned session and whether decision-making and social responses also vary with circadian timing. Risks are minimal and mainly relate to temporary tiredness when tested at a non-preferred time; participants may stop at any time. Participation is voluntary. Data are pseudonymized and handled under GDPR. Participants receive DKK 300 after completing both sessions (pro-rated if they withdraw early). Results will be published regardless of outcome, and de-identified data/code will be shared after publication.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 25, 2025
CompletedFirst Submitted
Initial submission to the registry
November 14, 2025
CompletedFirst Posted
Study publicly available on registry
December 18, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2027
December 22, 2025
October 1, 2025
1.5 years
November 14, 2025
December 19, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Time estimation bias
Signed percent error across 10, 30, and 60 s trials with a fixation cross: ((estimated - target)/target) × 100. Three trials per duration; session-level mean computed. Primary contrast: incongruent - congruent (within-subject). Higher values = overestimation.
Day 1 (once during each of the two laboratory sessions: morning and evening)
Secondary Outcomes (6)
Psychomotor Vigilance Task (PVT) lapses (count)
Day 1 (once during each of the two laboratory sessions: morning and evening)
Time production bias (neutral stimuli, 10-60 s)
Day 1 (once during each of the two laboratory sessions: morning and evening)
Duration discrimination threshold (2AFC adaptive)
Day 1 (once during each of the two laboratory sessions: morning and evening)
Subjective passage-of-time rating (VAS 0-100)
Day 1 (pre-, mid-, and post-session ratings during each of the two laboratory sessions)
Decision-making exploration rate (%) - Alien Game
Day 1 (once during each of the two laboratory sessions: morning and evening)
- +1 more secondary outcomes
Study Arms (2)
Sequence AB - Congruent → Incongruent
EXPERIMENTALrossover sequence AB. Participants first complete a circadian-congruent session (morning types in the morning; evening types in the evening), followed by a circadian-incongruent session (opposite time). Intervention administered: Behavioral - Session timing relative to chronotype.
Sequence BA - Incongruent → Congruent
EXPERIMENTALCrossover sequence BA. Participants first complete a circadian-incongruent session (opposite of their preferred time), then a circadian-congruent session. Intervention administered: Behavioral - Session timing relative to chronotype.
Interventions
Two-period, two-sequence crossover manipulation of testing time. Each participant completes both sessions: (1) circadian-congruent timing (morning types tested in the morning; evening types in the evening) and (2) circadian-incongruent timing (opposite time). Session order is randomized (AB/BA). Sessions are run morning and evening on the same day with a substantial interval; no visible clocks; 12-h pre-session caffeine/strenuous-exercise restriction; standardized lab light/temperature. Primary outcomes: time-estimation/production bias and PVT lapses/RT.
Eligibility Criteria
You may qualify if:
- Aged 23 to 45 years
- Able to understand and communicate in Danish
- Completed at least upper secondary education (e.g., gymnasium)
- Categorized as either a Morning Type (MT) or Evening Type (ET) based on standardized chronotype assessments:
- Munich Chronotype Questionnaire (MCTQ):
- MT: sleep midpoint on free days (MSFsc) ≤ 03:00
- ET: sleep midpoint on free days (MSFsc) ≥ 05:00
- Morningness-Eveningness Questionnaire (MEQ):
- One of four defined chronotype categories (definitely morning, moderately morning, moderately evening, definitely evening).
You may not qualify if:
- Current engagement in shift work, rotating schedules, or other forms of irregular sleep-wake timing
- Diagnosis of any neurological, psychiatric, or sleep-related disorder (e.g., insomnia, narcolepsy, sleep apnea)
- Use of medications that affect sleep, alertness, or circadian functioning (e.g., melatonin, stimulants, antidepressants)
- International travel across time zones within the four weeks preceding study participation
- Are classified as having an intermediate chronotype based on validated chronotype assessments (MCTQ or MEQ), as this group does not provide the necessary contrast to evaluate circadian alignment effects.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cognition and Behavior Lab
Aarhus, 8000, Denmark
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 14, 2025
First Posted
December 18, 2025
Study Start
October 25, 2025
Primary Completion (Estimated)
April 30, 2027
Study Completion (Estimated)
June 30, 2027
Last Updated
December 22, 2025
Record last verified: 2025-10